About the Symposium
Welcome back to our 3rd edition of Global Virtual Symposium on Toxoplasmosis (TOXO-2023) scheduled on January 23-24, 2023. The first inaugural symposium was held on Jan 18th, 2021, and second on Feb 8th, 2022. With a prodigious success of both virtual meetings, USG, United Scientific Group (a non-profit organization) proudly host this high-quality virtual conference again.
This year’s symposium will be a 2-day content-rich program will cover all the latest research findings in the area of basic/cell biology, pathology, immunology, epidemiology, ecology, and treatment of toxoplasmosis to control this wide-spread infection around the world.
Toxoplasmosis is a well-known disease that results from infection with the Toxoplasma gondii parasite and more than 40 million people in the world may be infected with the Toxoplasma parasite. Our speakers will report on a broad range of technologies; more fundamentally, they will share their creative and novel perspectives on developing new therapies to control toxoplasmosis.
TOXO-2023 will offer a unique opportunity for attendees to gain insights of the latest perspectives, updates, cutting-edge technological tools, and scientific advances in Toxoplasmosis research. We hope that you will enjoy this symposium and benefit from networking with attendees and speakers.
TOXO-2023 will bring together world-class clinicians, scientists, and investigators from this field. This virtual symposium will provide an ideal, cost-effective format with as it offers:
- Focused Presentations: on the latest in toxoplasmosis typically before publication.
- Great Speakers: Experience powerful education, learning, innovation by internationally recognized speakers.
- Networking Session: Connects with Internationally Renowned Researchers from all over the globe to network.
- Cost-saving: Engage without the expense and hassle of travel, hotel bookings, and spend your funds on Technology.
- Convenience: Attend from your home or work, without risk of travel.
We hope that you will enjoy this symposium and benefit from networking with attendees and speakers.
We look forward to welcoming you all on Jan 23rd virtually!
Symposium Chair: Vernon B. Carruthers, University of Michigan Medical School, MI, USA
Our Speakers
Angelo Scuotto
R&D Director, VaxinanoFrance
Aoife T. Heaslip
University of ConnecticutCT, USA
Bruno Martorelli Di Genova
The University of VermontVT, USA
Chris Tonkin
The Walter & Eliza Hall Inst. of Medical Research, Australia
Dominique Soldati-Favre
University of GenevaSwitzerland
Elena S. Suvorova
University of South FloridaFL, USA
Francesca Torelli
The Francis Crick Institute, United Kingdom
Hong-Juan Peng
Southern Medical University, China
Isabelle Coppens
John Hopkins UniversityMD, USA
John C. Samuelson
Boston UniversityMA, USA
Karen Shapiro
UC Davis School of Veterinary Medicine, CA, USA
Ke Hu
Arizona State University,AZ, USA
Kevin M. Brown
University of Oklahoma Health Sciences Center, OK, USA
Kirk D. C. Jensen
University of California, Merced, CA, USA
Laura Knoll
University of Wisconsin-Madison, WI, USA
Lena Pernas
Max Planck Institute for Biology of Ageing, Germany
Lilach Sheiner
University of GlasgowUnited Kingdom
Marc-Jan Gubbels
Boston CollegeMA, USA
Markus Meissner
Ludwig Maximilian University of Munich, Germany
Martin Blume
Robert Koch InstituteGermany
Mathieu Gissot
The Pasteur Institute of Lille, France
Melissa B Lodoen
University of CaliforniaCA, USA
Nishith Gupta
Birla Inst. of Tech. & Science (BITS), Hyderabad, India
Pikka Jokelainen
Statens Serum Institut, Denmark
Sergio Oscar Angel
National Scientific and Technical Research Council, Argentina
Silvia NJ Moreno
University of GeorgiaGA, USA.
Tania Dawant
University of TennesseeTN, USA
Tobias Steinfeldt
University of Freiburg, Germany
Vernon B. Carruthers
University of Michigan Medical School, MI, USA
Vicki Jeffers
University of New HampshireNH, USA
Yi-Wei Chang
University of PennsylvaniaPA, USA
Sponsor
Epeius pharma is a cell and gene therapy company developing next-generation biological vehicles to deliver therapeutic proteins into the central nervous system (CNS) and muscles. The lack of efficient CNS delivery methods limits protein replacement therapy and remains one of the greatest unmet needs for neurological disorders treatment. Our technology combing the naturally evolved BBB crossing capabilities of Toxoplasma gondii with state-of-the-art genetic manipulation tools to obtain optimal protein delivery. A toolbox developed by the company allow us to produce any gene-of-interest toxoplasma strains. Our off-the-shelf products utilize the toxoplasma secretion machinery to tailor made the protein expression for the relevant clinical indication — our POC product is designed to help Rett patients. For more information, please visit: https://www.futurx.co.il/portfolio/epeius-pharma/
Exhibitor
Abbexa is a worldwide supplier of biological tools for the life science, pharmaceutical development and biotechnology sectors. The company has branches in the UK, US and The Netherlands to serve customers worldwide. Abbexa provides the scientific community with primary antibodies, secondary antibodies, proteins, ELISA kits and enzymes as well as other kits and tools for use in research. Working with various laboratories across the world, the company aims to develop relevant, high quality, tested products for the biomedical research market, to meet needs at a reasonable price.
Abbexa is committed to providing scientists and researchers with the best customer experience and high quality products. The company provides the best support available, guaranteeing customer satisfaction. If the product doesn't meet expectations, the company offers an immediate replacement or refund. Please have a look at the quality guarantee for further details at https://www.abbexa.com/
Testimonials
"Thank you for organizing such a wonderful meeting!"
"Thanks for organizing this online event for Toxoplasma researchers. It was a very successful event. We had a group of excellent speakers in the meeting."
"This was a fantastic Symposium. I greatly enjoyed it…"
“Thank you very much for putting together a great symposium on toxoplasmosis! I enjoyed all the talks and learned a lot from great researchers in the Toxoplasma research field.”
“Thank you very much for all the hard work of you and your colleagues in organising this fantastic meeting. I really enjoyed it and thank you for giving us the opportunity to speak and take part. It was great to have the opportunity to catch up with some colleagues again and to meet new people working on Toxoplasma and I particularly enjoyed the wide variety of talks.”
"Thank you for this conference- it was excellent and very helpful, and i look forward to hearing more!"
“Thoroughly enjoyed participating in the meeting and found the talks very interesting and informative. Thanks for all your hard work putting the meeting together.”
“Thank you for the opportunity to take part in this Symposium. It was a pleasure.”
“It was an amazing conference! Thank you for the organization.”
“It was a pleasure, and I would be happy to participate in further events.”
"It was a great meeting. Wonderful presentations."
"It was a pleasure to participate in the meeting."